Mehak Suddle

Mehak Suddle, PharmD, currently serves as a Medical Science Liaison for Rare Disease and Hematology at Kedrion Biopharma, starting in January 2024. Previously, Mehak held the position of Senior Manager of Scientific Content at Karuna Therapeutics from April 2022 to December 2023, focusing on therapeutic areas such as schizophrenia and Alzheimer's disease psychosis. Prior experience includes working as a Senior Medical Science Liaison in Hematology at Sobi - North America, where responsibilities encompassed various therapeutic areas including hematology and supportive oncology. Mehak's earlier roles include postdoctoral fellowship at Takeda Oncology, adjunct faculty at MCPHS University, and medical writing at DAVA Oncology, along with multiple pharmacy externships. Mehak holds a Doctor of Pharmacy (PharmD) from the University of Maryland School of Pharmacy and a Bachelor of Science in Biology from St. Bonaventure University.